Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 6:45 PM
Study NCT ID:
NCT03942120
Status:
COMPLETED
Last Update Posted:
2025-04-27
First Post:
2019-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
Sponsor:
Janssen Korea, Ltd., Korea
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Crohn Disease | View |
Keywords: